Procurement Summary
Country: Czech Republic
Summary: Dns Lp 2026-007 - Akalabrutinib 2026
Deadline: 05 Jun 2026
Posting Date: 26 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 142064220
Document Ref. No.: SZ KZAS/037675/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
33652100 - Antineoplastic agents
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
The subject of the public contract is the provision of continuous supplies of medicinal products with the active ingredient AKALABRUTINIB for the needs of the contracting authority, as a provider of health services (not for the needs of resale/dispensing), including their direct shipment to pharmacies individual spin-off plants of the contracting authority, on the basis of a framework agreement concluded with one selected supplier for a period of 24 months from the conclusion of the framework agreement. Antineoplastics
DBID: 5118 System number: P26V00000171 File number: SZ KZAS/037675/2026 According to the law: No. 134/2016 Coll. Dynamic purchasing system: A dynamic purchasing system for the supply of medicinal products Start date: 25/05/2026 Submit the offer by: 06/05/2026 10:00 a.m Expected value: not specified
Documents
Tender Notice
cf1ab203b3dcf02acb881b26ed778ba7.vyzva.k.podani.nabidky.dns.lp.akalabrutinib.2026.pdf
c58573e9f32de9dc16f33ea98683db05.01.specifikace.a.podklad.pro.zpracovani.cenove.nabidky.akalabrutinib.2026.xlsx
ffe87cd0da01905b9eaa06a6e8f19312.02.ramcova.smlouva.akalabrutinib.2026.docx